Article Information
History
- January 24, 2022.
Article Versions
- You are currently viewing Version 1 of this article (January 24, 2022 - 17:42).
- View Version 2, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Lee Tatham1,4,
- Joanne Sharp1,4,
- Edyta Kijak1,4,
- Joanne Herriott1,4,
- Megan Neary1,4,
- Helen Box1,4,
- Anthony Valentijn1,4,
- Helen Cox1,4,
- Henry Pertinez1,4,
- Paul Curley1,4,
- Usman Arshad1,4,
- Rajith KR Rajoli1,4,
- Steve Rannard2,4,
- James Stewart3 and
- Andrew Owen1,4,*
- 1Department of Pharmacology and Therapeutics, Institute of Systems, Molecular and Integrative Biology, University of Liverpool, Liverpool, L7 3NY, UK
- 2Department of Chemistry, University of Liverpool, L7 3NY, UK
- 3Department of Infection Biology & Microbiomes, Institute of Infection, Veterinary and Ecological Sciences, University of Liverpool, UK
- 4Centre of Excellence in Long-acting Therapeutics (CELT), University of Liverpool, Liverpool, L7 3NY, UK
- ↵* Corresponding author; email: aowen{at}liverpool.ac.uk